Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing
Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)
Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5